Back
Protalix Biotherapeutics, Inc. Stock Predictions
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
45
PLX
Protalix Biotherapeutics, Inc.
Last Price:
$1.80
Seasonality Move:
85.19%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiProtalix Biotherapeutics, Inc. Stock Forecast
-
Is Protalix Biotherapeutics, Inc. Stock Undervalued?The current Protalix Biotherapeutics, Inc. [PLX] share price is $1.76. The Score for PLX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
PLX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Protalix Biotherapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Protalix Biotherapeutics, Inc. Stock Rating
Data Unavailable
Protalix Biotherapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protalix.com
52-Week Data
52-Week High:
3.10
52-Week Low:
1.32
Prediction Charts
Market Cap:
141.5M
Price in USD:
1.76
Volume:
588.7K
Beta:
1.27
Technical Analysis
SMA50:
2.05
SMA100:
1.91
SMA200:
1.96
52-Wk Change:
1.15%
Stock Predictions
-
Is Protalix Biotherapeutics, Inc. stock public?Yes, Protalix Biotherapeutics, Inc. is a publicly traded company.
-
What is the Protalix Biotherapeutics, Inc. stock quote today?The Protalix Biotherapeutics, Inc. stock price is 1.76 USD today.
-
How to buy Protalix Biotherapeutics, Inc. stock online?You can buy Protalix Biotherapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-28 | 1.83 | 1.78 | 1.85 | 1.78 |
| Dec-1 | 1.76 | 1.70 | 1.81 | 1.70 |
| Dec-2 | 1.72 | 1.67 | 1.76 | 1.65 |
| Dec-3 | 1.67 | 1.72 | 1.74 | 1.65 |
| Dec-4 | 1.71 | 1.75 | 1.78 | 1.69 |
| Dec-5 | 1.76 | 1.73 | 1.77 | 1.71 |
| Dec-8 | 1.71 | 1.74 | 1.78 | 1.68 |
| Dec-9 | 1.72 | 1.75 | 1.80 | 1.72 |
| Dec-10 | 1.73 | 1.80 | 1.83 | 1.73 |
| Dec-11 | 1.80 | 1.83 | 1.85 | 1.76 |
| Dec-12 | 1.81 | 1.79 | 1.86 | 1.76 |
| Dec-15 | 1.80 | 1.74 | 1.80 | 1.72 |
| Dec-16 | 1.74 | 1.81 | 1.83 | 1.74 |
| Dec-17 | 1.84 | 1.76 | 1.85 | 1.74 |
Protalix Biotherapeutics, Inc. Earnings
Data Unavailable
Protalix Biotherapeutics, Inc. Forecast Revenue Growth
Data Unavailable
* Protalix Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.